Table 4. Comparison between VDRL and TPHA titers in early syphilis patients with and without HIV.
Early Syphilis |
VDRL |
TPHA |
||
HIV (+) |
HIV (-) |
HIV (+) |
HIV (-) |
|
Baseline |
||||
Mean ± SD |
1:175 ± 1:424 |
1:31 ± 1:34 |
1:16,185 ± 1:16,681 |
1:3,237 ± 1:3,410 |
Median (range) |
1:64 (1:2-1:2,048) |
1:32 (1:2-1:128) |
1:7,680 (1:640-1:40,960) |
1:2,560 (1:80-1:10,240) |
p-value |
0.002 |
0.016 |
||
1 Month Follow-Up After Therapy |
||||
Mean ± SD |
1:51 ± 1:46 |
1:12 ± 1:10 |
1:8,064 ± 1:11,708 |
1:2745 ± 1:2,989 |
Median (range) |
1:32 (1:2-1:128) |
1:8 (1:1-1:32) |
1:2,560 (1:128-1:40,960) |
1:2,560 (1:80-1:10,240) |
p-value |
0.001 |
0.101 |
||
Last Follow-Up After Therapy |
||||
Mean ± SD |
1:42 ± 1:35 |
1:20 ± 1:34 |
1:9,867 ± 1:13,692 |
1:3132 ± 1:2,941 |
Median (range) |
1:32 (1:1-1:128) |
1:8 (1:1-1:128) |
1:3,840 (1:160-1:52,120) |
1:2,560 (1:80-10,240) |
p-value |
0.006 |
0.157 |